INDOCO REMEDIES LIMITED
Location
Maharashtra
Founded
1947-08-23
Website
Risk Signals
87 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about INDOCO REMEDIES LIMITED
Live alerts from global media, monitored by Business Radar
(economictimes.com)
Indoco Remedies gets warning letter from USFDA for Goa plant -
Indoco Remedies' Goa plant received a warning letter from the USFDA following a July inspection. The company stated its commitment to resolving the issues and maintaining compliance with US regulations while continuing to supply products to the US market. The company's shares saw a slight increase despite the warning.
Read more
(medicaldialogues.in)
Indoco Remedies Baddi facility bags EU GMP certification from Health Authority of Germany
The EU GMP certification issued by the German Health Authority (Berlin) confirms that the site complies with the Good Manufacturing Practice requirements as referred in the EC Directive.
Read more
(medicaldialogues.in)
USFDA inspection: Indoco Remedies gets 9 observations for Goa facility
Mumbai: Indoco Remedies has announced that the United States Food and Drug Administration (USFDA) has issued 9 observations after GMP inspection at the Solid Oral Formulation Facility (Plant 1) at...
Read more